We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-0.43%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$50.4B
AUM Growth
+$6.68B
(+15%)
Cap. Flow
+$7.39B
Cap. Flow
% of AUM
14.64%
Top 10 Holdings %
Top 10 Hldgs %
10.57%
Holding
2,337
New
201
Increased
1,161
Reduced
755
Closed
126
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$239M |
| 2 |
Valero Energy
VLO
|
+$171M |
| 3 |
Goldman Sachs
GS
|
+$159M |
| 4 |
Southwest Airlines
LUV
|
+$158M |
| 5 |
Allstate
ALL
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$213M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$213M |
| 3 |
Humana
HUM
|
+$162M |
| 4 |
PRE
PARTNERRE LTD
PRE
|
+$115M |
| 5 |
PPG Industries
PPG
|
+$98.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.78% |
| 2 | Technology | 15.29% |
| 3 | Financials | 14.29% |
| 4 | Consumer Discretionary | 11.78% |
| 5 | Industrials | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPRX
1626
DELISTED
Catalyst Pharmaceutical
CPRX
| $763K | ﹤0.01% |
184,782
| – | – |
|
1627
Harley-Davidson
HOG
$2.71B
| $762K | ﹤0.01% |
13,520
-33
| -0.2% | -$1.89K |
|
1628
Huron Consulting
HURN
$2.42B
| $761K | ﹤0.01% |
10,854
-6,773
| -38% | -$444K |
|
1629
Ligand Pharmaceuticals
LGND
$6.36B
| $760K | ﹤0.01% |
+12,069
| New | +$659K |
|
|
HOUS
1630
DELISTED
Anywhere Real Estate
HOUS
| $759K | ﹤0.01% |
16,245
+845
| +5% | +$39.3K |
|
1631
Coherent
COHR
$74.2B
| $757K | ﹤0.01% |
+39,876
| New | +$743K |
|
1632
Pacira BioSciences
PCRX
$997M
| $757K | ﹤0.01% |
10,703
-818
| -7% | -$64.4K |
|
1633
Generac Holdings
GNRC
$12.5B
| $756K | ﹤0.01% |
19,025
+5,700
| +43% | +$246K |
|
|
CBL
1634
DELISTED
CBL& Associates Properties, Inc.
CBL
| $753K | ﹤0.01% |
46,471
+10,171
| +28% | +$183K |
|
|
SGEN
1635
DELISTED
Seagen Inc. Common Stock
SGEN
| $749K | ﹤0.01% |
15,473
-56,027
| -78% | -$2.31M |
|
|
BLT
1636
DELISTED
BLOUNT INTERNATIONAL (NEW)
BLT
| $745K | ﹤0.01% |
68,175
-803
| -1% | -$9.84K |
|
1637
VSE Corp
VSEC
$6.12B
| $742K | ﹤0.01% |
27,742
+9,210
| +50% | +$306K |
|
|
PGNX
1638
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $742K | ﹤0.01% |
99,410
+36,510
| +58% | +$221K |
|
1639
Teledyne Technologies
TDY
$32B
| $739K | ﹤0.01% |
7,000
+1,542
| +28% | +$163K |
|
1640
Viatris
VTRS
$18.9B
| $739K | ﹤0.01% |
10,891
-100,022
| -90% | -$7.07M |
|
|
CNSL
1641
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $736K | ﹤0.01% |
35,009
-12,791
| -27% | -$266K |
|
1642
Citizens Financial Group
CFG
$30.6B
| $734K | ﹤0.01% |
26,884
+7,484
| +39% | +$198K |
|
1643
Empire State Realty Trust
ESRT
$836M
| $729K | ﹤0.01% |
42,723
-8,677
| -17% | -$156K |
|
1644
BorgWarner
BWA
$13.9B
| $724K | ﹤0.01% |
14,469
-2,272
| -14% | -$121K |
|
1645
Golar LNG
GLNG
$5.13B
| $722K | ﹤0.01% |
15,579
| – | – |
|
1646
Pricesmart
PSMT
$5.46B
| $721K | ﹤0.01% |
7,900
-417
| -5% | -$34.9K |
|
|
ARIA
1647
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $721K | ﹤0.01% |
87,187
-80,913
| -48% | -$716K |
|
1648
Phibro Animal Health
PAHC
$1.39B
| $719K | ﹤0.01% |
+18,453
| New | +$637K |
|
1649
Terreno Realty
TRNO
$7.49B
| $719K | ﹤0.01% |
36,506
+2,606
| +8% | +$55.2K |
|
1650
Insmed
INSM
$28.6B
| $716K | ﹤0.01% |
+29,320
| New | +$666K |
|
Similar funds
VGA
AQR Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, AQR Capital Management held 2,337 positions worth $50.4B, up 15% from $43.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
AQR Capital Management deployed $7.39B of net new capital in Q2 2015, opening 201 new positions and adding to 1,161 existing holdings. Its largest new stake was Darden Restaurants: 1,233,952 shares worth $78.4M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was AbbVie, an estimated $213M trimmed.
- AQR Capital Management's largest Q2 2015 buy was Darden Restaurants: 1,233,952 shares worth $78.4M.
- AQR Capital Management added most to UnitedHealth in Q2 2015, an estimated $239M increase.
- AQR Capital Management's biggest Q2 2015 reduction was AbbVie, cutting an estimated $213M.
- AQR Capital Management fully exited AOL INC COMMON STOCK in Q2 2015, selling an estimated $17.6M.
- AQR Capital Management's ten largest holdings make up 11% of its $50.4B portfolio in Q2 2015.
- AQR Capital Management opened 201 new positions and closed 126 in Q2 2015.
- AQR Capital Management's portfolio value rose 15% quarter-over-quarter to $50.4B.
Based on AQR Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.